“First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine (IPCAVD 001)”, J Infect Dis, vol. 207, pp. 240-247, 2013.
, “Induction of HIV-1-Specific Mucosal Immune Responses Following Intramuscular Recombinant Adenovirus Serotype 26 HIV-1 Vaccination of Humans”, J Infect Dis, vol. 211, pp. 518-528, 2015.
,